We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$6.17B
AUM Growth
-$5.56B
Cap. Flow
-$7B
Cap. Flow %
-113.41%
Top 10 Hldgs %
34.66%
Holding
1,572
New
83
Increased
30
Reduced
1,080
Closed
373

Sector Composition

Rank Sector Weight
1 Technology 15.69%
2 Consumer Discretionary 7.21%
3 Financials 6.09%
4 Consumer Staples 5.93%
5 Healthcare 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOEV
1176
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$21.3K ﹤0.01%
71
-84
-54% -$35.6K
LMDX
1177
DELISTED
LumiraDx Limited Common Shares
LMDX
$21.3K ﹤0.01%
45,738
-45,738
-50% -$43.8K
OPAD icon
1178
Offerpad Solutions
OPAD
$23.1M
$21.2K ﹤0.01%
268
-269
-50% -$26.7K
BFLY icon
1179
Butterfly Network
BFLY
$2.35B
$19.2K ﹤0.01%
10,230
-10,230
-50% -$23.9K
KRON
1180
DELISTED
Kronos Bio
KRON
$17.6K ﹤0.01%
12,034
-12,034
-50% -$23.1K
ATHX
1181
DELISTED
Athersys, Inc. Common Stock
ATHX
$17K ﹤0.01%
13,839
-16,937
-55% -$24.1K
WE
1182
DELISTED
WeWork Inc.
WE
$15.3K ﹤0.01%
491
-490
-50% -$26.8K
MRO
1183
CALL
DELISTED
Marathon Oil Corporation
MRO
$14.4K ﹤0.01%
6,000
FUBO icon
1184
FuboTV Inc
FUBO
$273M
$12.1K ﹤0.01%
833
-834
-50% -$19.1K
QMCO icon
1185
Quantum Corp
QMCO
$474M
$11.8K ﹤0.01%
513
-512
-50% -$13.4K
PLTR icon
1186
PUT
Palantir
PLTR
$413B
$11.8K ﹤0.01%
+50,000
New +$391K
DOMA
1187
DELISTED
Doma Holdings, Inc.
DOMA
$10.2K ﹤0.01%
1,000
-3,343
-77% -$44.9K
NKTR icon
1188
Nektar Therapeutics
NKTR
$2.58B
$9.95K ﹤0.01%
944
-1,601
-63% -$48.4K
XLY icon
1189
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$9.39K ﹤0.01%
+2,600
New +$186K
UP icon
1190
Wheels Up
UP
$198M
$8.51K ﹤0.01%
67
-67
-50% -$14.9K
BX icon
1191
PUT
Blackstone
BX
$110B
$7.6K ﹤0.01%
5,000
+400
+9% +$35.3K
YPF icon
1192
CALL
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$4.58K ﹤0.01%
+7,500
New +$82.5K
CDAK
1193
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2.97K ﹤0.01%
17,000
-13,000
-43% -$7.24K
NAVB
1194
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$2.61K ﹤0.01%
10,043
-10,043
-50% -$2.93K
AAON icon
1195
Aaon
AAON
$7.77B
-4,155
Closed -$209K
AAP icon
1196
Advance Auto Parts
AAP
$3.49B
-7,364
Closed -$940K
AAPL icon
1197
CALL
Apple
AAPL
$4.57T
0
-$20.8K
ABEV icon
1198
Ambev
ABEV
$46.4B
-26,848
Closed -$45.4K
ABG icon
1199
Asbury Automotive
ABG
$3.85B
-1,261
Closed -$226K
ABM icon
1200
ABM Industries
ABM
$2.84B
-6,014
Closed -$267K

Similar funds

Pathstone Family Office's Q1 2023 Portfolio in Review

As of Q1 2023, Pathstone Family Office held 1,572 positions worth $6.17B, down 47% from $11.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Pathstone Family Office withdrew a net $7B in Q1 2023, closing 373 positions and reducing 1,080 holdings. Its most notable exit was ZimVie, an estimated $72.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Pathstone Family Office opened a new position in iShares MSCI Emerging Markets ex China ETF worth $11.3M.

  • Pathstone Family Office's largest Q1 2023 buy was iShares MSCI Emerging Markets ex China ETF: 229,043 shares worth $11.3M.
  • Pathstone Family Office added most to Dimensional Core Fixed Income ETF in Q1 2023, an estimated $61.4M increase.
  • Pathstone Family Office's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $429M.
  • Pathstone Family Office fully exited ZimVie in Q1 2023, selling an estimated $72.7M.
  • Pathstone Family Office's ten largest holdings make up 35% of its $6.17B portfolio in Q1 2023.
  • Pathstone Family Office opened 83 new positions and closed 373 in Q1 2023.
  • Pathstone Family Office's portfolio value fell 47% quarter-over-quarter to $6.17B.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.